Apellis Pharmaceuticals I... (APLS)

22.64

0.77 (3.52%)

At close: Apr 01, 2025, 3:59 PM

22.24

-1.75%

After-hours: Apr 01, 2025, 05:17 PM EDT

Apellis Pharmaceuticals Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-197.88M	-528.63M	-652.17M	-746.35M	-344.87M
Depreciation & Amortization	1.8M	1.7M	1.49M	1.49M	637K
Stock-Based Compensation	114.13M	105.94M	91.08M	70.67M	45.38M
Other Working Capital	n/a	-200.34M	32.63M	-77.59M	19.64M
Other Non-Cash Items	-5.91M	26.41M	61.55M	6.33M	15.76M
Deferred Income Tax	n/a	n/a	n/a	198.26M	103.03M
Change in Working Capital	n/a	-200.17M	-15.7M	-93.52M	19.59M
Operating Cash Flow	-87.87M	-594.74M	-513.75M	-563.13M	-160.49M
Capital Expenditures	-403K	-773K	-1.52M	-1.1M	-5.42M
Acquisitions	n/a	n/a	-61.42M	-248.72M	311.57M
Purchase of Investments	n/a	n/a	-331.86M	-171.28M	-879.07M
Sales Maturities Of Investments	n/a	n/a	393.28M	420M	567.5M
Other Investing Acitivies	n/a	99K	61.42M	248.72M	-311.57M
Investing Cash Flow	-403K	-674K	59.89M	247.62M	-316.99M
Debt Repayment	365.45M	n/a	n/a	n/a	322.87M
Common Stock Repurchased	4.51M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-216.21M	10.11M	-14.46M	11.87M	369.3M
Financial Cash Flow	149.24M	394.5M	365.66M	392.24M	692.18M
Net Cash Flow	60.31M	-200.78M	-88.68M	74.71M	215.06M
Free Cash Flow	-88.27M	-595.51M	-515.27M	-564.23M	-165.91M